Transderm-V
Brand names,
Transderm-V
Analogs
Transderm-V
Brand Names Mixture
Transderm-V
Chemical_Formula
C17H21NO4
Transderm-V
RX_link
No information avaliable
Transderm-V
fda sheet
Transderm-V
msds (material safety sheet)
Transderm-V
Synthesis Reference
No information avaliable
Transderm-V
Molecular Weight
303.353 g/mol
Transderm-V
Melting Point
No information avaliable
Transderm-V
H2O Solubility
No information avaliable
Transderm-V
State
Solid
Transderm-V
LogP
1.659
Transderm-V
Dosage Forms
Liquid
Transderm-V
Indication
For the treatment of excessive salivation, colicky abdominal pain, bradycardia, sialorrhoea, diverticulitis, irritable bowel syndrome and motion sickness.
Transderm-V
Pharmacology
Scopolamine is a muscarinic antagonist structurally similar to the neurotransmitter acetylcholine and acts by blocking the muscarinic acetylcholine receptors and is thus classified as an anticholinergic. Scopolamine has many uses including the prevention of motion sickness. It is not clear how Scopolamine prevents nausea and vomiting due to motion sickness. The vestibular part of the ear is very important for balance. When a person becomes disoriented due to motion, the vestibule sends a signal through nerves to the vomiting center in the brain, and vomiting occurs. Acetylcholine is a chemical that nerves use to transmit messages to each other. It is believe that Scopolamine prevents communication between the nerves of the vestibule and the vomiting center in the brain by blocking the action of acetylcholine. Scopolamine also may work directly on the vomiting center. Scopolamine must be taken before the onset of motion sickness to be effective.
Transderm-V
Absorption
No information avaliable
Transderm-V
side effects and Toxicity
No information avaliable
Transderm-V
Patient Information
No information avaliable
Transderm-V
Organisms Affected
Humans and other mammals